BridgeMD
New treatment option for Shin Splint
Official title Effects of Autogenic Inhibition and Reciprocal Inhibition in Amateur Football Players With Shin Splints.
ClinicalTrials.gov ID: NCT06501430
What this study is testing
- What it's testing
- This randomized controlled trial aims to compare the effectiveness of Autogenic Inhibition and Reciprocal Inhibition in treating shin splints among amateur footballers aged 18-30 from SA Gardens Football Club, Lahore. Participants will be recruited through non-probability convenient sampling and randomly assigned into two groups using random number sampling.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Both genders.
- Age 18-30 years.
- Those who are actively taking part in sports from last 1 year.
- people who have NPRS scores from moderate pain (NPRS 4-6) to severe pain (NPRS 7- 10).
- people diagnosed with category 2 Shin splints through Shin splint scoring system (Male 2- 14, Female 6-16) and category 3 (Male 14-29, Female 17-29).
You likely can't join if
- History of Central or peripheral vascular disease.
- History of lower limb fracture / Trauma (Any side) in last 6 months.
- History of lower limb Surgery (Any side) in last 6 months.
- History of any malignancy.
- Leg length discrepancy.
- Biomechanical imbalances.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.